DIA Biosimilars 2013

RaySearch Laboratories

RaySearch enters agreement with Chinese distributor

Tuesday, November 29, 2011 12:55 PM
RaySearch Laboratories has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the entire Chinese market.

More... »

Cenduit: Now with Patient Reminders

RaySearch signs South Korean distribution agreement with OTS

Wednesday, November 23, 2011 11:04 AM
RaySearch Laboratories has entered into an exclusive distribution agreement with the South Korean distributor Oncology Total Solution, based in Seoul. The agreement means that OTS will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the South Korean market.

More... »

CRF Health – eCOA Forum

The University Hospital selects RayStation for advanced research

Friday, October 21, 2011 02:06 PM

RaySearch Laboratories has received an order for its RayStation treatment planning system from The University Hospital of Columbia and Cornell in New York.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs